Mode
Text Size
Log in / Sign up
N/A N=20 Treatment

The Development of a Personalized, Real-time Intervention

Drinking, Alcohol

Enrolled (actual)
20
Serious AEs
10.0%
Results posted
Nov 2022
Primary outcome: Primary: Drinking Motives Questionnaire-Revised (DMQ-R) Coping Motive — 2.15 score on a scale — p=<.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PFIcope+EMI (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Butler Hospital
Primary completion
May 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Drinking Motives Questionnaire-Revised (DMQ-R) Coping Motive
2.15 <.05 sig
PRIMARY
Percentage of Days of Alcohol Use in the Last Month
19 <.01 sig

Summary

The investigators propose to enhance our existing coping motive-specific normative feedback intervention (PFIcope intervention) by capitalizing on EMA/EMI technology to pair real-time affective monitoring with tailored real-time relapse prevention texts for individuals with anxiety and depression who drink to cope. The goals of the PFIcope+EMI study are to help individuals to identify motives for drinking and to utilize alternate coping strategies for negative affect in place of alcohol.

Eligibility Criteria

Inclusion Criteria

(a) between 18 and 25 years of age, (b) reported alcohol use at least 3x weekly over past month, (c) self-reported use of coping motive (mean of 2+ on coping subscale of MDMQ-R), (d) current anxiety and/or depression symptomatology (as assessed CES-D score of 16+ and GAD-7 scores 10+), (e) has access to a smartphone capable of receiving EMA and text, and access to email.

Exclusion Criteria

(a) current DSM-5 diagnosis of moderate/severe other substance use disorder (i.e., other than alcohol), (b) a history of psychotic disorder or current psychotic symptoms, (c) current suicidal/homicidal ideation.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03518619). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search